PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 239,500
-15,500 (-6.08%)
Oct 23, 2026, 3:30 PM KST
PharmaResearch Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, PharmaResearch stock has a consensus rating of "Strong Buy" and an average price target of ₩509,429. The average 1-year stock price forecast is 112.71% higher than the current stock price, while the lowest is ₩430,000 (+79.54%) and the highest is ₩620,000 (+158.87%).
Price Target: ₩509,429 (+112.71%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PharmaResearch stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 9 | 9 | 9 |
| Buy | 6 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Financial Forecast
Revenue This Year
699.78B
from 536.29B
Increased by 30.49%
Revenue Next Year
842.52B
from 699.78B
Increased by 20.40%
EPS This Year
19.67K
from 14.93K
Increased by 31.71%
EPS Next Year
23.62K
from 19.67K
Increased by 20.08%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.